StockData
Danaher Corp logo

Danaher Corp

DHRNYSEIndustrial Instruments For Measurement, Display, and ControlFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 25, 2026Last filing: 10-Q on Oct 21, 2026Score 13/3018% above fair value
$227.97−4.26 (-1.83%)

Close on Nov 2, 2026Market cap $160.26BP/E 37.3Yield –

Danaher HemoCue (Point-of-Care POC Hematology Testing) by Month

HemoCue (Point-of-Care POC Hematology Testing) — MAUDE Adverse Event Reports

QuarterlyAnnualMonthly

Danaher HemoCue (Point-of-Care POC Hematology Testing): 0 in Sep 2026. That is the lowest of the 116 months on record here.

Latest, Sep 2026
0
Period ended Sep 30, 2026
Change on a year earlier
–
0 in Sep 2025
History
116 months
Since Feb 2015
Sources
1
U.S. FDA openFDA API (510(k), PMA, Recalls, Enforcement, MAUDE)

Where the Sep 2026 figure comes from

Source: U.S. FDA openFDA API (510(k), PMA, Recalls, Enforcement, MAUDE) ↗

Reported in U.S. FDA openFDA MAUDE Adverse Event API.

Monthly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedHemoCue (Point-of-Care POC Hematology Testing) — MAUDE Adverse Event ReportsYear on yearSource
Sep 2026Sep 30, 20260–U.S. FDA openFDA API (510(k), PMA, Recalls, Enforcement, MAUDE) ↗
Aug 2026Aug 31, 20260–U.S. FDA openFDA API (510(k), PMA, Recalls, Enforcement, MAUDE) ↗
Jul 2026Jul 31, 20260–U.S. FDA openFDA API (510(k), PMA, Recalls, Enforcement, MAUDE) ↗
Jun 2026Jun 30, 20260–U.S. FDA openFDA API (510(k), PMA, Recalls, Enforcement, MAUDE) ↗
May 2026May 31, 20260–U.S. FDA openFDA API (510(k), PMA, Recalls, Enforcement, MAUDE) ↗
Apr 2026Apr 30, 20260–U.S. FDA openFDA API (510(k), PMA, Recalls, Enforcement, MAUDE) ↗
Mar 2026Mar 31, 20260–U.S. FDA openFDA API (510(k), PMA, Recalls, Enforcement, MAUDE) ↗
Feb 2026Feb 28, 20260–U.S. FDA openFDA API (510(k), PMA, Recalls, Enforcement, MAUDE) ↗
Jan 2026Jan 31, 20260–U.S. FDA openFDA API (510(k), PMA, Recalls, Enforcement, MAUDE) ↗
Dec 2025Dec 31, 20250–U.S. FDA openFDA API (510(k), PMA, Recalls, Enforcement, MAUDE) ↗
Nov 2025Nov 30, 20250–U.S. FDA openFDA API (510(k), PMA, Recalls, Enforcement, MAUDE) ↗
Oct 2025Oct 31, 20250–U.S. FDA openFDA API (510(k), PMA, Recalls, Enforcement, MAUDE) ↗
Sep 2025Sep 30, 20250–U.S. FDA openFDA API (510(k), PMA, Recalls, Enforcement, MAUDE) ↗
Aug 2025Aug 31, 20250–U.S. FDA openFDA API (510(k), PMA, Recalls, Enforcement, MAUDE) ↗
Jul 2025Jul 31, 20250–U.S. FDA openFDA API (510(k), PMA, Recalls, Enforcement, MAUDE) ↗
Jun 2025Jun 30, 20250–U.S. FDA openFDA API (510(k), PMA, Recalls, Enforcement, MAUDE) ↗

Cite this data

StockData. (2026). Danaher HemoCue (Point-of-Care POC Hematology Testing), monthly Feb 2015–Sep 2026 [Data set]. Compiled from Danaher SEC filings and investor materials. https://stockdatahq.com/stocks/dhr/kpis/ext-fda-maude-hemocue

See every metric in the Danaher KPI table. Data updated Nov 2, 2026.

See a number that looks wrong?